'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release.
The authorization includes those 12 and up based on modeling that shows it would have similar effects in children as in adults if they were a certain weight, but Pfizer said in its release that the data from the new trial"will provide further support for the dose recommendations in this population, as well as potentially expand the indication to younger age groups and lower weights."
"There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death," said Dr. Mikael Dolsten, Pfizer's chief scientific officer and president of worldwide research, development and medical, in the release.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
UK to phase out import of Russian oil and oil products by the end of 2022According to a statement released by the UK government, the UK will phase out its imports of Russian oil and oil products by the end of 2022, reported
Read more »
EU to phase out Russian gas, oil, coal imports - leaders' draftEuropean Union leaders will agree at a summit this week to phase out the EU's dependency on imports of Russian gas, oil and coal, a draft statement showed, marking a turning point in its policy towards Moscow prompted by Russia's invasion of Ukraine.
Read more »
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Pfizer Starts Testing Its Covid-19 Pill in ChildrenPfizer expects results from its study of the Covid-19 drug Paxlovid in high-risk children by the end of the year
Read more »